Table 4.
Staphylococcus strains used in this study.
| Staphylococcus Strains | Relevant Properties | Source |
|---|---|---|
| S. aureus | ||
| USA300 | Wilde type strain | L.N. Shaw [47] |
| ATCC 25923 | Clinical isolate | ATCC |
| Newman | Wilde type laboratory strain | T.J. Foster |
| 56A1 | Clinical isolate | * |
| 52B | Clinical isolate | * |
| 1694 | Clinical isolate | * |
| 2492 | Clinical isolate | * |
| 2706 | Clinical isolate | * |
| 2872cv | Clinical isolate | * |
| 3417 | Clinical isolate | * |
| 4187 | Clinical isolate | * |
| 6674 | Clinical isolate | * |
| 7219 | Clinical isolate | * |
| 7501 | Clinical isolate | * |
| 7569 | Clinical isolate | * |
| 7718 | Clinical isolate | * |
| S. epidermidis | ||
| ATCC 12228 | Wilde type strain | ATCC |
* The clinical strains were collected from nonrelated patients admitted to the Stefan Zeromski Specialist Muncipal Hospital in Krakow, Poland.